908 Devices Dips After Wider-Than-Expected 3Q Loss

Dow Jones11-11
 

By Elias Schisgall

 

Shares of 908 Devices slipped after the maker of chemical-analysis devices reported a wider-than-expected loss and lower revenue.

The stock fell 11%, to $6.55 a share, midday Monday, but has nearly tripled year-to-date.

The company posted a third-quarter loss of $15 million, or 41 cents a share, compared with a loss of $29.3 million, or 84 cents a share, a year earlier.

Analysts surveyed by FactSet expected a loss of about 14 cents a share.

The Boston company reported $14 million in revenue, a 4% decrease from the year before.

It said it continues to expect full-year revenue between $54 million and $56 million. Analysts are expecting $55.4 million.

 

Write to Elias Schisgall at elias.schisgall@wsj.com

 

(END) Dow Jones Newswires

November 10, 2025 15:10 ET (20:10 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment